BD (NYSE:BDX) today announced the introduction of the Elyra thulium fiber laser (TFL) system for treating kidney stones.

The Elyra TFL system is available in two versions, Elyra and Elyra Plus.

BD (NYSE:BDX) has introduced the Elyra Thulium Fiber Laser System for kidney stone treatment, aiming to improve efficiency and flexibility in urologic procedures. The company also restated a long term ...

On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...

In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

Global medtech giant BD announced that it is adding capacity to its US-based footprint for the production of critical medical devices, including syringes, needles, and IV catheters. As part of the ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters. As part of a $10 million investment in 2024, new ...

Becton, Dickinson has introduced an AI cloud-based platform to unify all of its medical device data into one place. The BD Incada Connected Care Platform will go hand-in-hand with BD’s Pyxis Pro ...